Professor John Simes is Senior Principal Research Fellow, Founder and Director of the CTC.
He is a leading international researcher in clinical trials, particularly in cancer, cardiovascular disease, diabetes and neonatal medicine. He has contributed to over 350 peer-reviewed articles, with many having a significant impact on current knowledge and clinical practice.
John is the Founding Director and a current board member of the Sydney Catalyst Translational Research Centre, a virtual centre of cancer researchers in central Sydney and regional NSW. He is a founding member of the Board of Directors of ACTA.
John is a practicing medical oncologist in neuro-oncology at Royal Prince Alfred Hospital and the Chris O’Brien Lifehouse and is Professor of Clinical Epidemiology, Faculty of Medicine, University of Sydney. He was awarded the Cancer Achievement Award for lifetime achievement in oncology by the Medical Oncology Group of Australia (2010) and the Distinguished Harvard Alum Award (Biostatistics) from Harvard University (2009) in recognition of his work in research. He has recently been elected as a Fellow of the Australian Academy of Health and Medical Sciences and was named on the Clarivate Analytics 2018 Highly Cited Researchers List for 2018.